In silico site of metabolism prediction for human UGT-catalyzed reactions

Bioinformatics

Volumn 30, Issue 3, 2014, Pages 398-405

  Peng, Jianlong ^a   Lu, Jing ^a   Shen, Qiancheng ^a   Zheng, Mingyue ^a   Luo, Xiaomin ^a   Zhu, Weiliang ^a   Jiang, Hualiang ^a,b   Chen, Kaixian ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCURONOSYLTRANSFERASE;

ARTICLE; BIOCATALYSIS; CHEMISTRY; COMPUTER SIMULATION; HUMAN; METABOLISM; SUPPORT VECTOR MACHINE;

BIOCATALYSIS; COMPUTER SIMULATION; GLUCURONOSYLTRANSFERASE; HUMANS; SUPPORT VECTOR MACHINES;

EID: 84893279081     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btt681     Document Type: Article

References (45)

1. Brown, R.E. and Simas, A.M. (1982) On the applicability of CNDO indices for the prediction of chemical reactivity. Theor. Chim. Acta., 62, 1-16.
2. Burges, C.J.C. (1998) A tutorial on support vector machines for pattern recognition. Data Min. Knowl. Disc., 2, 121-167.
3. Chang, C.C and Lin, C.J. (2001) LIBSVM: a library for support vector machines. http://www.csie.ntu.edu.tw/cjlin/libsvm/.
4. Cnubben, N.H.P., et al. (1994) Molecular orbital-based quantitative structureactivity relationship for the cytochrome P450-catalyzed 4-hydroxylation of halogenated anilines. Chem. Res. Toxicol., 7, 590-598.
5. CODESSA, v 2.7.2. Semichem, Inc. 1995-2004. Shawnee, KS 66216.
6. Cupid, B.C., et al. (1999) Quantitative structure-metabolism relationships (QSMR) using computational chemistry: pattern recognition analysis and statistical prediction of phase II conjugation reactions of substituted benzoic acids in the rat. Xenobiotica, 29, 27-42.
7. Ethell, B.T., et al. (2002) Quantitative structure activity relationships for the glucuronidation of simple phenols by expressed human UGT1A6 and UGT1A9. Drug Metab. Dispos., 30, 734-738.
8. Fawcett, T. (2006) An introduction to ROC analysis. Pattern Recognit. Lett., 27, 861-874.
9. Gonzalez, M.P., et al. (2008) Variable selection methods in QSAR: an overview. Curr. Top. Med. Chem., 8, 1606-1627.
10. Guyon, I., et al. (2002) Gene selection for cancer classification using support vector machines. Mach. Learn., 46, 389-422.
11. Hawkins, D.M. (2004) The problem of overfitting. J. Chem. Inf. Comp. Sci., 44, 1-12.
12. Karelson, M., et al. (1996) Quantum-chemical descriptors in QSAR/QSPR studies. Chem. Rev., 96, 1027-1043.
13. Katritzky, A.R., et al. (1995-1997) CODESSA Reference Manual, version 2.0. Semichem and the University of Florida, Gainesville, Florida.
14. Kawada, H., et al. (2013) Lead optimization of a dihydropyrrolopyrimidine inhibitor against phosphoinositide 3-kinase (PI3K) to improve the phenol glucuronic acid conjugation. Bioorg. Med. Chem. Lett., 23, 673-678.
15. Kennard, R.W. and Stone, L.A. (1969) Computer aided design of experiments. Technometrics, 11, 137-148.
16. Kerdpin, O., et al. (2009) Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP- glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10. Drug Metab. Dispos., 37, 1948-1955.
17. Kilpatrick, G.J. and Smith, T.W. (2005) Morphine-6-glucuronide: actions and mechanisms. Med. Res. Rev., 25, 521-544.
18. Kim, K.H. (1991) Quantitative structure-activity relationships of the metabolism of drugs by uridine diphosphate glucuronosyltransferase, J. Pharm. Sci., 80, 966-970.
19. Lemnaru, C. and Potolea, R. (2012) Imbalanced classification problems: systematic study, issues and best practices. In: Enterprise Information Systems. Springer, Berlin Heidelberg, pp. 35-50.
20. Magdalou, J., et al. (2010) Insights on membrane topology and structure/function of UDP-glucuronosyltransferases. Drug Metab. Rev., 42, 159-166.
21. Matthews, B.W., et al. (1975) Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochem. Biophys. Acta, 405, s442-s452.
22. Mercier, C., et al. (1991) Modeling alcohol metabolism with the Darc Calphi system. J. Med. Chem., 34, 934-942.
23. Miley, M.J., et al (2007) Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7. J. Mol. Biol., 369, 498-511.
24. Millan, D.S., et al. (2011) Design and synthesis of inhaled p38 inhibitors for the treatment of chronic obstructive pulmonary disease. J. Med. Chem., 54, 7797-7814.
25. Miners, J.O. and Mackenzie, P.I. (1991) Drug glucuronidation in humans. Pharmacol. Ther., 51, 347-369.
26. Miners, J.O., et al. (2004) Predicting human drug glucuronidation parameters: application of in vitro and in silico modeling approaches. Annu. Rev. Pharmacol., 44, 1-25.
27. Mulliken, R.S. (1955) Electronic population analysis on LCAO-MO molecular wave functions. 1. J. Chem. Phys., 23, 1833-1840.
28. OBoyle, N.M., et al. (2011) Open babel: an open chemical toolbox. J. Cheminf., 3, 33.
29. Rowland, A., et al. (2013) The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification. Int. J. Biochem. Cell Biol., 45, 1121-1132.
30. Smith, P.A., et al. (2003a) In silico insights: Chemical and structural characteristics associated with uridine diphosphate-glucuronosyltransferase substrate selectivity. Clin. Exp. Pharmacol. Physiol., 30, 836-840.
31. Smith, P.A., et al. (2003b) Pharmacophore and QSAR modeling: complementary approaches for the rationalization and prediction of UDP-glucuronosyltransferase 1A4 substrate selectivity. J. Med. Chem., 46, 1617-1626.
32. Sorich, M.J., et al. (2003) Comparison of linear and nonlinear classification algorithms for the prediction of drug and chemical metabolism by human UDPglucuronosyltransferase isoforms. J. Chem. Inf. Comp. Sci., 43, 2019-2024.
33. Sorich, M.J., et al. (2004a) Rapid prediction of chemical metabolism by human UDP-glucuronosyltransferase isoforms using quantum chemical descriptors derived with the electronegativity equalization method. J. Med. Chem., 47, 5311-5317.
34. Sorich, M.J., et al. (2004b) Multiple pharmacophores for the investigation of human UDP-glucuronosyltransferase isoform substrate selectivity. Mol. Pharmaco.l, 65, 301-308.
35. Sorich, M.J., et al. (2006) The importance of local chemical structure for chemical metabolism by human uridine 5 -diphosphate - glucuronosyltransferase. J. Chem. Inf. Model., 46, 2692-2697.
36. Stewart, J.J.P. (1990) Special issue - mopac - a semiempirical molecular-orbital program. J. Comput. Aided Mol. Des., 4, 1-45.
37. Sybyl, v 6.8. Tripos Inc. 2001. St. Louis, MO 63144-2913.
38. Tanaka, R., et al. (2007) Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potential. Bioorg. Med. Chem., 15, 1363-1382.
39. Temellini, A., et al. (1991) Human liver sulphotransferase and UDP-glucuronosyltransferase: structure-activity relationship for phenolic substrates. Xenobiotica, 21, 171-177.
40. Vapnik, V. (1999) The Nature of Statistical Learning Theory (Information Science and Statistics) . Springer, New York.
41. Vashishtha, S.C., et al. (2001) Quaternary ammonium-linked glucuronidation of 1- substituted imidazoles: studies of human UDP-glucuronosyltransferases involved and substrate specificities. Drug Metab. Dispos., 29, 1290-1295.
42. Wang, Y., et al. (2010) Using support vector regression coupled with the genetic algorithm for predicting acute toxicity to the fathead minnow. SAR QSAR Environ. Res., 21, 559-570.
43. Wildman, S.A. and Crippen, G.M. (1999) Prediction of physicochemical parameters by atomic contributions. J. Chem. Inf. Comp. Sci., 39, 868-873.
44. Wu, W.L., et al. (2005) Dopamine D1/D5 receptor antagonists with improved pharmacokinetics: design, synthesis, and biological evaluation of phenol bioisosteric analogues of benzazepine D1/D5 antagonists. J. Med. Chem., 48, 680-693.
45. Zheng, M., et al. (2009) Site of metabolism prediction for six biotransformations mediated by cytochromes P450. Bioinformatics, 25, 1251-1258.